Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PARP inhibitors: will the new class of drugs match the hype?

× No keyword cloud information.

10 in total

Review 1. Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics.

Authors: Jin-xue He; Chun-hao Yang; Ze-hong Miao
Journal: Acta Pharmacol Sin Date: 2010-08-02 Impact factor: 6.150

2. Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells.

Authors: Fengfeng Cai; Isabell Ge; Minghong Wang; Ewelina Biskup; Xiaoyan Lin; Xiaoyan Zhong
Journal: Tumour Biol Date: 2013-12-15

3. Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment.

Authors: Shawnta Coleman; Prema P Peethambaram; Aminah Jatoi
Journal: J Cancer Educ Date: 2011-09 Impact factor: 2.037

4. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.

Authors: Robert S Crawford; Hassan Albadawi; Marvin D Atkins; John E Jones; Hyung-Jin Yoo; Mark F Conrad; W Gerald Austen; Michael T Watkins
Journal: Surgery Date: 2010-02-04 Impact factor: 3.982

Review 5. Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Authors: Frédérique Mégnin-Chanet; Marc A Bollet; Janet Hall
Journal: Cell Mol Life Sci Date: 2010-08-20 Impact factor: 9.261

6. Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).

Authors: Eric Tram; Irada Ibrahim-Zada; Laurent Briollais; Julia A Knight; Irene L Andrulis; Hilmi Ozcelik
Journal: Breast Cancer Res Date: 2011-08-11 Impact factor: 6.466

7. PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Authors: Kristine M Frizzell; W Lee Kraus
Journal: Breast Cancer Res Date: 2009-11-26 Impact factor: 6.466

8. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors: Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal: Mol Cancer Date: 2009-12-31 Impact factor: 27.401

9. BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.

Authors: William Jacot; Simon Thezenas; Romain Senal; Cathy Viglianti; Anne-Claire Laberenne; Evelyne Lopez-Crapez; Frédéric Bibeau; Jean-Pierre Bleuse; Gilles Romieu; Pierre-Jean Lamy
Journal: BMC Cancer Date: 2013-11-05 Impact factor: 4.430

10. Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study.

Authors: Eva Gross; Harm van Tinteren; Zhou Li; Sandra Raab; Christina Meul; Stefanie Avril; Nadja Laddach; Michaela Aubele; Corinna Propping; Apostolos Gkazepis; Manfred Schmitt; Alfons Meindl; Petra M Nederlof; Marion Kiechle; Esther H Lips
Journal: BMC Cancer Date: 2016-10-19 Impact factor: 4.430

10 in total